A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 6, 2009

Primary Completion Date

June 1, 2011

Study Completion Date

June 1, 2011

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

PF-04360365 10 mg/kg

10 mg/kg every 90 days (5 total doses)

BIOLOGICAL

PF-04360365 7.5 mg/kg

10 mg/kg loading dose followed by 7.5 mg/kg monthly maintenance dosing (total of 13 doses)

DRUG

placebo

placebo administered every 90 days or monthly to match experimental treatment arms.

Trial Locations (4)

413 45

Sahlgrenska Sjukhuset, CTC, Gothenburg

205 02

Malmo Sjukhus, Neuropsykiatriska Kliniken, Malmo

431 41

Sahlgrenska Universitetssjukhuset, Minnesmottagningen, Mölndal

141 86

Karolinska Universitetssjukhuset Huddinge, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00945672 - A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter